In conclusion, urea administration appears to be a safe and useful treatment for SIADH-associated hyponatremia in critically ill patients. The low cost of this treatment in comparison with vaptans should encourage its use
In conclusion, urea administration appears to be a safeand useful treatment for SIADH-associated hyponatremiain critically ill patients. The low cost of this treatment incomparison with vaptans should encourage its use